Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

Clinical trial NCT02759289 · COMPLETED

Trial details

NCT number: NCT02759289
Sponsor: NYU Langone Health
Status: COMPLETED
Study type: OBSERVATIONAL

Atherosclerosis Type 2 Diabetes (T2D)

Start date: 2015-11-01
Primary completion: 2020-09-15
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.